Metabolic syndrome and heart failure--the risk, paradox, and treatment.
about
Serum Angiopoietin-Like Protein 2 Concentrations Are Independently Associated with Heart FailureMuscle mass index as a predictor of longevity in older adultsNoncardiac comorbidities in heart failure with reduced versus preserved ejection fractionMetabolic syndrome, aging and involvement of oxidative stressShort-chain fatty acid propionate alleviates Akt2 knockout-induced myocardial contractile dysfunction.Hypothalamic inflammation: a double-edged sword to nutritional diseases.Inflammatory cause of metabolic syndrome via brain stress and NF-κB.Plasma phospholipid fatty acid composition and estimated desaturase activity in heart failure patients with metabolic syndromeComorbid Heart Failure and Renal Impairment: Epidemiology and Management.Inverse association of long-acting natriuretic peptide with metabolic syndrome in congestive heart failure patientsDirect effects of adipokines on the heart: focus on adiponectin.Functional foods and nutraceuticals as therapeutic tools for the treatment of diet-related diseases.The role of adiponectin signaling in metabolic syndrome and cancer.Effect of bariatric surgery on heart failure.Early cardiac dysfunction is rescued by upregulation of SERCA2a pump activity in a rat model of metabolic syndrome.
P2860
Q28548351-439D04B6-139B-48EF-AAC6-89FFCC46E2BFQ33670921-E0E6EC1A-00CE-4462-8C8E-895FB070D5E9Q34625223-406551DF-0366-44E0-9002-FCBCC968A6F2Q35195226-3A5989BB-236D-4ACE-8D6F-E87DC975F399Q35231890-71E5D8C5-F51D-41F4-A5B6-1FC2245A86E3Q35318592-19B073BC-3B79-4D5A-A963-F454553BB83AQ35857192-1ADA17C9-B44D-4FA3-93F5-CB3F5F46D89BQ36205467-6F9E345A-7265-44F5-B62F-654AA597DD94Q36551356-9C22E91D-7315-4179-8160-8AE62F739C6FQ36794070-E2DC6789-7285-45B2-AAB1-52653492D940Q38034678-FB925C7A-20B3-4EBF-A08D-1699165523D2Q38112775-3F7CE610-7380-40ED-9C67-52CC282923E5Q38135763-10F916D6-8A23-465D-A15C-D74B3250645EQ48116252-39FCC391-9C76-4E65-B2C6-1FFD88AEADE2Q51434807-CB6962F4-8616-4822-8E4A-4A94868BCE28
P2860
Metabolic syndrome and heart failure--the risk, paradox, and treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metabolic syndrome and heart failure--the risk, paradox, and treatment.
@en
Metabolic syndrome and heart failure--the risk, paradox, and treatment.
@nl
type
label
Metabolic syndrome and heart failure--the risk, paradox, and treatment.
@en
Metabolic syndrome and heart failure--the risk, paradox, and treatment.
@nl
prefLabel
Metabolic syndrome and heart failure--the risk, paradox, and treatment.
@en
Metabolic syndrome and heart failure--the risk, paradox, and treatment.
@nl
P2093
P2860
P1476
Metabolic syndrome and heart failure--the risk, paradox, and treatment.
@en
P2093
Carl J Lavie
Hector O Ventura
Krishna K Gaddam
P2860
P2888
P304
P356
10.1007/S11906-011-0179-X
P577
2011-04-01T00:00:00Z